WST Stock Jumps on Q1 Earnings & Sales Beat, EPS View Up on HVP Growth

West Pharmaceutical posts 46.9% EPS growth and beats estimates as strong segment demand lifts revenues, prompting a higher 2026 outlook and margin expansion.